Lexeo Therapeutics宣布FDA加速审批途径讨论取得进展,Lx2006治疗弗里德赖希共济失调心肌病临床数据积极

美股速递
Oct 07

Lexeo Therapeutics宣布,公司在FDA加速审批途径的讨论中取得进展,同时其药物Lx2006在弗里德赖希共济失调心肌病治疗方面的中期临床数据呈现积极结果。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10